Carlini Institute

Lung cancer remains one of the most significant health challenges facing the United Kingdom today, accounting for more deaths each year than any other cancer type. With advances in surgical technique, radiotherapy, immunotherapy, and precision medicine accelerating at an unprecedented pace, the quality and expertise of the specialist treating you can make a profound difference to your outcome. Choosing the right oncologist or thoracic surgeon is one of the most important decisions a patient and their family will ever make, and the landscape of talent available across the UK in 2026 is genuinely world-class.
This guide has been compiled to help patients, GPs, and referring clinicians navigate that landscape with confidence. The ten specialists featured here represent the very best the UK has to offer across clinical oncology and thoracic surgery, bringing together decades of experience, landmark research, and a shared commitment to delivering exceptional, patient-centred care. Whether you are seeking a diagnosis, a second opinion, or a treatment plan, the names on this list are an excellent starting point for your journey.
Before exploring individual specialists, it is worth understanding what separates a good oncologist from a genuinely outstanding one. Lung cancer treatment today demands a blend of disciplines. A leading specialist will typically hold deep expertise in at least one of the following:
The very best in the field tend to span more than one of these domains, contributing to multidisciplinary teams (MDTs) that bring a full range of perspectives to every patient's care pathway. Track record, peer-reviewed publication output, surgical volume, and patient outcomes are all meaningful indicators of clinical excellence.
The NHS offers excellent lung cancer services across the country, and many of the specialists below practise in both NHS and private settings, making them accessible to a wide range of patients. Private oncology has grown considerably in recent years, particularly in London, enabling faster access to consultations, cutting-edge diagnostics, and novel therapies that may not yet be routinely available on the NHS. When researching a specialist, it is worth considering:
With those criteria in mind, here are the ten lung cancer specialists most worthy of your attention in 2026.
Dr. James Wilson is widely regarded as one of the leading figures in lung cancer oncology in the United Kingdom. A Consultant Clinical Oncologist based in central London, Dr. Wilson holds appointments at some of the country's most prestigious cancer centres, including The Cromwell Hospital, The London Clinic, Icon Cancer Centre, and GenesisCare UK. His clinical practice spans the full spectrum of thoracic malignancies, with particular expertise in non-small cell lung cancer (NSCLC), small-cell lung cancer, mesothelioma, and thymoma. Patients who come to Dr. Wilson benefit not only from a highly experienced clinician but from someone who has built an exceptional reputation for personalised, innovative care.
What distinguishes Dr. Wilson from many of his peers is the scope of his treatment toolkit. He is a recognised specialist in stereotactic ablative radiotherapy (SABR), a highly precise form of radiation treatment used for early-stage lung cancers and oligometastatic disease. This technique, delivered with pinpoint accuracy over a small number of sessions, has transformed outcomes for patients who are not surgical candidates, and Dr. Wilson is among the most experienced practitioners of this approach in the UK. His ability to integrate radiotherapy with systemic treatments, including immunotherapy and targeted therapy, allows him to offer truly comprehensive management plans tailored to each patient's molecular profile and clinical circumstances.
Dr. Wilson's practice is notably accessible. He does not require a GP referral for private consultations, which means that patients seeking fast access to expert opinion can book directly and receive timely assessment without navigating lengthy referral pathways. This commitment to accessibility reflects a broader philosophy that informs everything about his work: that patients facing a lung cancer diagnosis deserve prompt, expert attention and the respect of being fully informed partners in their own care.
Beyond his clinical practice, Dr. Wilson maintains an active presence in medical education and patient communication, including through online resources designed to demystify lung cancer treatment for patients and families. His reputation among referring clinicians is outstanding, and patients consistently praise his thoroughness, clarity, and compassion. For anyone navigating a lung cancer diagnosis in the UK in 2026, Dr. James Wilson represents the gold standard of oncological care.
Prof. Vladimir Anikin is a Consultant Thoracic Surgeon at Harefield Hospital, part of the Royal Brompton and Harefield NHS Foundation Trust, one of the most celebrated cardiorespiratory centres in the world. His career trajectory is remarkable: he received his initial thoracic surgical oncology training at the PA Hertzen Cancer Research Institute in Moscow in the early 1980s before going on to build a distinguished career in the United Kingdom, accumulating over four decades of experience in the surgical management of thoracic malignancies. That depth of expertise makes him one of the most experienced thoracic surgeons currently practising in the country.
Prof. Anikin's areas of clinical expertise are broad and include:
His prolific research output, with over 80 peer-reviewed publications and more than 1,100 citations, underscores his standing as a clinical academic of significant stature. Patients referred to Prof. Anikin can be confident they are in the care of a surgeon who combines encyclopaedic technical knowledge with the nuanced clinical judgement that comes only from a lifetime at the operating table. His work at Harefield Hospital places him within a multidisciplinary environment of the highest calibre, with access to world-leading diagnostic and post-operative support infrastructure.
Miss Elizabeth Belcher is a Consultant Thoracic Surgeon at Oxford University Hospitals NHS Foundation Trust, operating primarily out of the John Radcliffe Hospital. She is a recognised authority in minimally invasive thoracic surgery and has contributed significantly to the academic understanding of optimal lung cancer resection in the UK. Her 2021 paper, published in BMJ Open Respiratory Research, examined the question of optimal resection rates for lung cancer across UK surgical centres and has been widely cited as an important contribution to the evidence base shaping national surgical standards.
Miss Belcher's practice reflects the modern consensus that wherever possible, a thoracoscopic or robotic-assisted approach offers superior outcomes for patients, including shorter recovery times, reduced post-operative complications, and equivalent oncological results compared to open surgery. Registered with the Society for Cardiothoracic Surgery (SCTS), she combines a rigorous academic approach with a strong commitment to patient welfare. Her involvement in the English National Lung Cancer Clinical Outcomes Programme ensures that her work is benchmarked against the very best national standards, and patients at Oxford University Hospitals benefit from the comprehensive MDT infrastructure that supports her practice.
What sets Miss Belcher apart is the dual force of her clinical and academic influence. Her research on resection rates and surgical outcomes has helped inform policy discussions about access to surgery for lung cancer patients across the country, a cause that has real and tangible consequences for patient survival. Her published work explores not only technical outcomes but the systemic factors that affect whether patients are offered surgery at all, a perspective that reveals a clinician deeply invested in improving the population-level impact of her specialty.
Patients seeking surgical treatment for lung cancer in the south of England, particularly in the Thames Valley and South Central region, will find in Miss Belcher an experienced, thoughtful, and academically grounded surgeon whose outcomes reflect a dedication to excellence in every dimension of thoracic surgical practice.
Mr. Julius Asante-Siaw serves as both a Consultant Thoracic Surgeon and Clinical Lead for Thoracic Surgery at Liverpool Heart and Chest Hospital (LHCH), one of the largest and most active specialist thoracic surgical units in the United Kingdom. His dual role in clinical leadership and frontline surgical practice places him at the very centre of one of the country's most progressive lung cancer programmes. In 2025, under his leadership, LHCH performed the first laser-assisted lung cancer surgery in Cheshire and Merseyside, a significant milestone that reflects the unit's culture of surgical innovation and its commitment to offering patients access to the latest and most effective techniques.
Patients treated by Mr. Asante-Siaw benefit from being embedded within the Liverpool Lung Cancer Unit's comprehensive ecosystem of care, which brings together surgeons, oncologists, radiologists, pathologists, and clinical nurse specialists in a cohesive MDT framework. This structure enables each patient's case to be assessed holistically, with treatment decisions made collaboratively and backed by the collective expertise of the full team.
Mr. Asante-Siaw's leadership ethos is defined by a clear ambition: to improve outcomes for lung cancer patients through a combination of surgical excellence, institutional innovation, and the adoption of emerging technologies. His work with laser-assisted surgery is one illustration of this commitment, but it is far from the only one. He has been a consistent advocate for reducing delays in the lung cancer treatment pathway, recognising that timeliness is itself a clinical intervention.
For patients in the North West of England, Mr. Asante-Siaw and the team at Liverpool Heart and Chest Hospital represent an exceptional resource. His standing as Clinical Lead, combined with his reputation for personalised, compassionate surgical care, makes him one of the most compelling choices for patients seeking expert thoracic surgical opinion in the region.
Mr. Joel Dunning is a Consultant Cardiothoracic Surgeon at James Cook University Hospital in Middlesbrough, South Tees Hospitals NHS Foundation Trust, and one of the most recognisable figures in UK thoracic surgery. With over 5,800 citations to his published research and 157 peer-reviewed publications, his academic footprint is extraordinary by any measure. His clinical expertise centres on lung cancer surgery, with a particular focus on VATS (video-assisted thoracoscopic surgery) lobectomy and thymectomy, areas in which he has not only developed considerable personal expertise but has worked to raise standards nationally through training initiatives, surgical education, and published guidelines.
Mr. Dunning is perhaps uniquely distinguished for his contribution to surgical education. His presence on platforms like CTSNet, the global network for cardiothoracic surgical professionals, and his prolific involvement in national and international teaching programmes have helped disseminate best practice to a new generation of thoracic surgeons. His work exemplifies the idea that the best clinicians invest not only in their own patients but in raising the quality of care across the entire healthcare system.
Mr. Dunning's team at James Cook University Hospital has been at the forefront of developing and refining minimally invasive approaches to lung cancer surgery in the NHS setting. His advocacy for VATS lobectomy, at a time when many centres still defaulted to open surgery, contributed meaningfully to the national shift towards less invasive techniques that are now considered the standard of care for eligible patients. Patients operated on by Mr. Dunning benefit from a surgeon whose technical experience is matched by an evidence-based approach informed by his own research and by the global surgical literature he has helped to shape.
His geographical base in the North East of England means he serves a region that historically has faced significant disparities in lung cancer outcomes, and his work at James Cook University Hospital provides patients in that region with access to a standard of care that rivals the best centres in the country.
Mr. Doug West is a Consultant Thoracic Surgeon at University Hospitals Bristol and Weston NHS Foundation Trust, where he has held his consultant post since 2011. His prominence in the UK thoracic surgery landscape extends well beyond his clinical role: he serves as Deputy Clinical Lead (Surgery) for the National Lung Cancer Audit and was previously the SCTS Audit Lead for thoracic surgery, roles that place him at the heart of the national conversation about measuring, benchmarking, and improving surgical outcomes for lung cancer patients across England. He has also served as a GIRFT (Getting It Right First Time) clinical lead, a national programme designed to reduce unwarranted clinical variation and improve patient outcomes across NHS services.
Mr. West qualified from Edinburgh Medical School in 1997, completed his basic surgical training at the Hammersmith Hospital in London, and undertook specialist training that spanned Scotland, Yorkshire, and beyond. His sub-specialty interest in minimally invasive thoracic surgery reflects the direction of travel across the discipline, and his patient outcomes at Bristol have been consistently strong.
What makes Mr. West's contribution particularly valuable is the integration of his clinical and audit work. By leading the National Lung Cancer Audit, he has direct access to the most comprehensive data available on surgical outcomes across the UK, and that perspective inevitably informs the quality of his own clinical decision-making. Surgeons who engage deeply with outcomes data tend to be among the most rigorous and reflective practitioners in any specialty.
For patients in the South West of England, Mr. West offers access to a nationally recognised thoracic surgeon whose track record in lung cancer surgery is underpinned by a deep commitment to evidence-based practice and continuous improvement. His work at Bristol Royal Infirmary is conducted within a well-established thoracic surgical unit that brings together a team of experienced consultants and supporting specialists.
Mr. Francesco Di Chiara, MS THOR (Hons), FEBTS, MD, is a Consultant Thoracic Surgeon at the John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, where he is credited with introducing uniportal VATS surgery to the unit. This technique, which approaches the chest through a single small incision, represents the cutting edge of minimally invasive thoracic surgery and requires a high level of technical skill and experience to perform safely and effectively. Mr. Di Chiara qualified from the world-renowned Padua Medical School in Italy and subsequently trained across cardiac, thoracic, and lung transplantation surgery in both Italy and the United Kingdom, bringing an unusually broad surgical foundation to his practice.
Having entered his consultant role in 2016, Mr. Di Chiara has rapidly established himself as one of the more dynamic and technically innovative surgeons of his generation. His fellowship training as a cardiopulmonary retrieval transplant fellow gives him expertise in cardiopulmonary physiology that enriches his surgical judgement in complex lung cancer cases where cardiac reserve and pulmonary function are critical considerations.
Mr. Di Chiara's specialist interests are notably wide-ranging and include:
This breadth reflects a thoracic surgeon genuinely committed to managing the full spectrum of thoracic pathology, not only the most common conditions. His affiliation with Bupa and Nuffield Health, in addition to his NHS role at Oxford University Hospitals, makes him accessible to both NHS and private patients, and his growing profile at the European Association for Cardio-Thoracic Surgery (EACTS) signals a surgeon who is becoming increasingly influential at the international level.
Mr. Tim Batchelor, MBChB BSc MSc FRCS(CTh), is a Consultant Thoracic Surgeon at the Barts Thorax Centre, St Bartholomew's Hospital in London, one of the most important thoracic surgical units in the UK. He is internationally recognised as the Thoracic Surgery Clinical Lead for the ERAS (Enhanced Recovery After Surgery) Society and is the principal author of the international ERAS guidelines for lung cancer surgery. These guidelines, which aim to optimise patient preparation and recovery through evidence-based pre-operative, intra-operative, and post-operative protocols, have been adopted by surgical units across the world and represent a genuine contribution to improving surgical outcomes globally.
Mr. Batchelor graduated from Edinburgh University Medical School in 1995 and completed his cardiothoracic surgical training in Scotland and Yorkshire before establishing himself as a leading figure at the forefront of thoracic surgical quality improvement. His sub-specialty interests include thoracoscopic surgery, small-cell and non-small-cell lung cancer surgery, and lung volume reduction, reflecting a comprehensive engagement with the full range of thoracic surgical challenges.
The development and dissemination of the ERAS guidelines for thoracic surgery represents a body of work that has had a measurable impact on patient recovery times, complication rates, and length of hospital stay for lung cancer surgery patients worldwide. Mr. Batchelor's leadership in this area speaks to a surgical mind that looks beyond the operating theatre and asks broader questions about how the system of care surrounding surgery can be optimised to serve patients better.
At the Barts Thorax Centre, patients benefit from access to one of London's most experienced and well-resourced thoracic surgical teams, within which Mr. Batchelor occupies a position of significant expertise and seniority. For patients in London and the surrounding region seeking lung cancer surgery informed by the very latest evidence-based protocols, Mr. Batchelor is a standout choice.
Miss Susannah Love is a Consultant Thoracic Surgeon at Liverpool Heart and Chest Hospital, a centre that has earned a national reputation as one of the largest and most active thoracic surgical units in the United Kingdom. She is a recognised specialist in lung cancer surgery, oesophageal cancer, and the management of complex thoracic conditions, and her standing among colleagues and patients alike reflects the quality and consistency of her clinical work. Her recognition as Employee of the Month at LHCH speaks to qualities that extend beyond technical skill, namely a warmth, dedication, and commitment to patient welfare that patients frequently cite as central to their experience of care.
Miss Love was among the team involved in the landmark first laser-assisted lung cancer surgery in Cheshire and Merseyside, a milestone that placed Liverpool Heart and Chest Hospital at the vanguard of surgical innovation in the North West. Her involvement in this advance reflects an ethos shared by the wider LHCH thoracic team: a continuous drive to offer patients access to the most effective and least invasive surgical options available.
Miss Love's practice encompasses the full range of thoracic conditions seen in a high-volume specialist unit. Alongside primary lung cancer surgery, her interests include pulmonary metastasectomy, the surgical removal of secondary tumours that have spread to the lung from other primary cancers, an area in which she has engaged with the research literature, including contributing to work on the role of metastasectomy in metastatic breast cancer. This breadth of practice enables her to offer meaningful surgical input across a wide range of complex oncological scenarios.
For patients in Cheshire, Merseyside, and the wider North West, Miss Susannah Love represents an accessible, highly experienced, and deeply committed thoracic surgical specialist within a unit that is genuinely among the best in the country.
Mr. Mike Shackcloth is a Consultant Thoracic Surgeon at Liverpool Heart and Chest Hospital and one of the most decorated thoracic surgeons of his generation. In 2024, he was awarded the Golden Lungs Trainer Award, a national accolade that recognises outstanding commitment to surgical training and education in the thoracic specialty. This recognition is a fitting reflection of a career defined not only by surgical excellence but by a genuine investment in developing the next generation of thoracic surgeons. His research output is substantial, with over 150 peer-reviewed publications and more than 9,100 citations, placing him among the most cited thoracic surgical researchers in the UK.
Mr. Shackcloth's specialist clinical interests include:
His involvement in lung cancer CT screening advocacy reflects a broader commitment to earlier diagnosis, which remains one of the most powerful levers for improving lung cancer survival in the UK.
Beyond his surgical practice, Mr. Shackcloth serves as a member of the national committee of BASO: The Association for Cancer Surgery, contributing to the shaping of national cancer surgical standards at the highest level. His advocacy for lung volume reduction therapy and his engagement with CT screening programmes demonstrate a clinician who understands that saving lives requires engagement with the full pathway, from prevention and early detection through to definitive surgical treatment and post-operative rehabilitation.
For patients at Liverpool Heart and Chest Hospital and across the North West, Mr. Shackcloth represents a rare combination of surgical mastery, academic distinction, and an unwavering commitment to improving the quality and accessibility of lung cancer care.
Facing a lung cancer diagnosis is one of the most challenging experiences a person can encounter, but the calibre of specialist care available across the United Kingdom in 2026 provides genuine cause for optimism. The ten specialists featured in this guide represent a cross-section of the UK's finest clinical talent, surgeons and oncologists who combine technical mastery with active research programmes, institutional leadership, and a deep commitment to the patients in their care. Whether you are seeking a consultation in London, the North West, the South West, or the East Midlands, expert help is within reach. Taking the time to find the right specialist for your specific diagnosis and clinical circumstances is not only worthwhile, but it may be the most important step you take on your treatment journey.
Copyright 2000 - 2013 Carlini Institute All rights reserved. Alternative Healing On-line Distance Courses
Carlini Institute